Skip to content
Skip to footer

Back to McKesson.com Home

Business Services and Solutions

Our integrated approach combines expert advisory services and cutting-edge technology to help you overcome challenges, identify opportunities, and improve your pharmacy’s performance.

Explore
- Professional & Advisory Services
  
  Improve your pharmacy's business performance with McKesson's Professional & Advisory Services (P&AS). By leveraging deep industry knowledge and advanced analytics, we help you improve operations so you can achieve more for the business of pharmacy.
  
  Specialty and Infusion Solutions for Health Systems
  
  Specialty Pharmacy
  
  Payer Solutions
  
  340B Advisory
  
  340B Impact
  
  Contract Concierge
  
  Orphan Drug Support Program
- Additional Business Solutions
  
  Our extensive portfolio of business solutions empowers health system pharmacies to achieve more by improving operations and driving business growth. Leveraging technology-driven platforms and strategic guidance, we provide actionable insights to address critical challenges, including supply chain management, revenue cycle optimization, 340B drug pricing, and more.
  
  Macro Helix™/ RxO
  
  Class of Trade Optimization
  
  SupplyLogix®
  
  EnterpriseRx®
Pharmaceutical Products and Distribution

It's time to expect more from your pharmaceutical distributor. Let us provide the perspective, focus, and execution you need to help the business of pharmacy achieve more for the advancement of patient health. Our innovative distribution strategies and suite of pharmaceutical products empower your health system to focus on your commitment on advancing value-based care.

Explore
- Pharmaceutical Products
  
  Our expansive portfolio is designed to support the continuum of care, from groundbreaking biosimilar innovations and essential generics to life-changing orphan drugs and revolutionary cell and gene therapies. Additionally, our robust supply assurance strategies ensure that you can depend on a consistent and timely delivery of the medications your patients rely on.
  
  Biosimiliars
  
  Branded and Generic Products
  
  Orphan Drugs
  
  Cell, Gene, & Advanced Therapies
  
  Supply Assurance
- McKesson Plasma & Biologics
  
  As demand for specialty pharmaceuticals and biologics continues to rise and add complexity to the supply chain, we’re responding with new distribution strategies to seamlessly deliver. McKesson Plasma and Biologics offers customers an expansive portfolio of plasma-derived products, biologics and other specialty drugs at competitive prices from a single source that has deep experience in specialized patient care. 
- Ordering and Reporting
  
  McKesson's innovative ordering and reporting solutions are designed to help health systems achieve more for the business of pharmacy. Our comprehensive platforms allow your pharmacy to streamline operations, optimize inventory and make data-driven decisions.
  
  McKesson Enterprise Reporting & Analytics (ERA)
  
  Connect Ordering
  
  Rapid Returns
Industry News and Insights

Staying informed on the latest industry news and insights is critical in achieving more for the business of pharmacy. Within Prescribed Perspectives, you’ll find exclusive articles, podcasts, eBooks, research, and additional resources authored by our health system experts that can help your health system pharmacy with operational efficiency, cost-saving strategies, and more.

Explore
- Prescribed Perspectives Insights Center
  
  A dedicated resource for health system teams to access valuable industry insights and cost-saving strategies.
  
  Research
  
  Case Studies
  
  eBooks
  
  Industry Webinars
  
  View All
  
  Subscribe Now
- Our Authors
  
  With unique industry knowledge and first-hand experience across virtually all areas of health system pharmacy, our authors and experts are dedicated to helping you achieve more.
- Insights by Topic
  
  Get straight to the insights that matter most to your health system.
  
  C-Suite Considerations
  
  340B
  
  Specialty Pharmacy
  
  Supply Chain & Distribution
  
  MHS in the News
  
  View All
- Industry Conferences and Events
  
  Join us at upcoming healthcare and pharmacy conferences to connect with our industry-leading experts, gain valuable insights, discover innovative solutions, and participate in strategic discussions that advance the future of health system pharmacy.
Contact Health Systems

Ready to achieve more for the business of pharmacy? Contact us today to discover how McKesson's innovative business services and solutions can help improve your operations and drive financial success.

Contact Us Now
- Contact Health Systems
  
  Contact Us
  
  Communications Preference Center
- Industry Conferences and Events
  
  Join us at upcoming healthcare and pharmacy conferences to connect with our industry-leading experts, gain valuable insights, discover innovative solutions, and participate in strategic discussions that advance the future of health system pharmacy.

Achieve More by Successfully Navigating the New World of 340B Contract Pharmacy

Importance of transparency when addressing a changing 340B environment.

By McKesson Health Systems Editorial Team

Date

September 12, 2022

By: Heather Easterling and Andrew Wilson

Read time: 1 minute

Since 2020, drug manufacturers have implemented policies restricting the purchase of 340B-priced drugs for covered entities when dispensing through contract pharmacies and the result is contributing to financial losses for safety-net hospitals.

Watch the 340B Tips, Tricks, and Traps webinar as we explore this ever-changing environment and how transparency is at the center of it all.

552 - 340B Webinar - Navigating the New World

Subscribe Now

To learn how McKesson can help health systems achieve more, sign up to have the Prescribed Perspectives newsletter delivered directly to your inbox.

Related Stories

Researcher in a laboratory looks through shelving lined with containers and supplies.

What You Should Know About the CMS Proposed 340B Payment Change

Dr. Andrew Wilson, B.S., Pharm.D., FASHP, reflects on the proposed CY 2027 OPPS rule for several outpatient drugs purchased through the 340B program, and the next phase of specialty drug margin management for the business of pharmacy.

Waterfront cityscape at sunset with reflections on the water and a Ferris wheel in the distance. Provide your feedback on BizChat

Event Recap: 2026 340B Coalition Summer Conference Highlights

At this year's event, our experts engaged with health system leaders to better understand the priorities, challenges, and opportunities shaping the future of 340B.

Two people walk through a warehouse aisle beside automated equipment and stacked inventory.

Central Pharmacy Service Centers That Achieve More for Health Systems

Recommendations to unlock enterprise value through a modern CSC

Person scans a medication package barcode beneath a digital workstation screen in a pharmacy dispensing environment.

How Modern Central Pharmacy Service Centers Drive Enterprise Pharmacy Performance

A guide to reframing centralization as enterprise enablement to achieve more for the business pharmacy.

Two lab professionals in white coats review documents and tablet in a pharmacy or lab setting with shelves of bottles in background.

Redefining Pharmacy’s Workforce for a More Complex Care Era

As care delivery grows more complex, health system pharmacists must expand their skill sets to deliver the patient-centered experiences modern healthcare demands.

Group of business professionals walk and talk in a bright glass hallway, some holding folders and coffee, moving between offices.

Upcoming Event: THMA Pharmacy Growth Collaborative

Executive dialogue and peer-driven insights shaping the future of health system pharmacy

Interactive 340B and IRA Resource Library text on a background with light blue and yellow geometric shapes.

Stay Informed on the Evolving 340B and IRA Landscape

Use this comprehensive library of resources to find important information on what’s changing with 340B and IRA, when, and why it may matter for your health system pharmacy.

Text asks if health systems can change perceptions of generic drugs, with two medicine bottles and a blurred pharmacy background.

Is the Health System Pharmacy in the Perfect Position to Change the Perception of Generic Drugs?

Consider the four “P’s” of generic drugs that support the case for wider adoption of generics in the health system and beyond.

Person in a suit with earphones holding a smartphone; podcast title on 340B changes and health system impact is overlaid.

Podcast: Monitoring Ongoing 340B Changes and the Potential Impact for Health Systems

One of our McKesson experts discusses the importance of staying informed as 340B changes continue to unfold.

Cityscape with buildings reflecting sunlight, viewed across calm water at sunset.

Event Recap: 2025 340B Coalition Summer Conference Brings Resource Constraints – and Solutions – to the Conversation

At this year's event, our experts heard from health systems who may be underutilizing available tools and resources in 340B program management.

Related Tags